Tags : Alexander Gutmans


Walder Wyss advises BC Platforms with USD 20m growth financing 

Walder Wyss has advised BC Platforms,  an expert of data science solutions for personalized healthcare, drug discovery and life science research, in connection with the CHF 20 million (approx. USD 20 million) growth financing round. This growth equity financing was led by new investor Jolt Capital, a fully independent private equity firm that specialises in […]

Deal & transactions

Walder Wyss on the acquisition of groupe.id by Elvaston

The groupe. id has been acquired by German private equity firm Elvaston Capital Management. Based in La Chaux-de-Fonds and also present in Yverdon-les-Bains, the groupe.id is a renowed Swiss provider of enterprise resource planning software solutions. Founded in 1982, the Swiss group develops and delivers technological services with high added value, especially in terms of […]

Deal & transactions

Walder Wyss on the sell of Magnolia to GENUI

Elvaston, an entrepreneur-led private equity firm, has sold its participation in Magnolia International to GENUI. The investment company has acquired a majority stake in Magnolia and will injects significant growth capital into the company. Magnolia is a Swiss based digital experience software company, developing and distributing a digital experience platform as well as a content […]

Banking & Finance

ImmunOs Therapeutics Raises USD 74 Million Series B Financing Round

ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL Capital, PEAK6 Strategic Capital, and Fiscus Financial, as well as existing investors Pfizer Ventures, BioMed Partners, and Schroder Adveq. […]

Deal & transactions

DSM and Firmenich to merge in 42 billion EURO deal

DSM and Firmenich have entered into a business combination agreement to establish the leading creation and innovation partner in nutrition, beauty and well-being. The Dutch specialty chemicals maker has said that this merge with Swiss peer Firmenich in a deal involving shares and cash will position them as leaders and major player in the fast-growing […]

Banking & Finance

Engimmune Therapeutics raises CHF 15.5m in seed financing round 

Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch.  Engimmune Therapeutics is a platform company using cutting-edge technologies to engineer highly potent and specific TCR-based therapies for cancer treatment.  Proceeds from the financing will be used to develop novel T-cell […]

Banking & Finance

Kooky secures financing of EUR 6 million for further expansion  

kooky, a brand of Zurich-based CEBS, focuses on developing alternative solutions for disposable tableware, has secured an addition EURO 6 million for expansion to Germany and Austria. Early-stage venture capital fund, UVC Partners acted as main investor in this additional financing round, alongside, well-known business angels such as Delivery Hero CFO Emmanuel Thomassin or the […]

Banking & Finance

Memo Therapeutics closes Series B Financing at CHF 37m .

Memo Therapeutics, specialists in the field of antibody discovery and development, has closed an oversubscribed Series B financing round led by Swisscanto Invest at CHF37 million after securing an additional CHF23 million from a combination of strategic and financial investors, including Adjuvant Capital, Fresenius Medical Care Ventures, GF Group, Verve Ventures, Vesalius Biocapital and Zürcher […]